Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services is presoliciting the acquisition of the Agilent NovoCyte Advanteon Flow Cytometer, a benchtop system for high-parameter cellular analysis. This advanced platform will enhance research workflows in gene regulation studies, crucial for developing new therapeutic approaches for diseases like cancer and diabetes.
The NovoCyte Advanteon Flow Cytometer is a benchtop system designed for high-parameter cellular analysis in research and clinical laboratory settings. It is an advanced platform for multicolor flow cytometry that combines flexible hardware configurations with automated data acquisition and analysis capabilities. The Section on Regulatory Ribonucleic Acids conducts research on the regulation of gene expression by ribonucleic acid binding proteins and micro ribonucleic acids. These studies are critical to understanding how gene regulation is disrupted in diseases such as cancer, hearing loss, and diabetes. Understanding these processes supports the development of new therapeutic approaches. Acquisition of the NovoCyte Advanteon Flow Cytometer will significantly increase experimental throughput and improve the efficiency of research workflows supporting these projects.
Agilent NovoCyte Advanteon Flow Cytometer is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.